CVE-2025-27953: n/a
An issue in Clinical Collaboration Platform 12.2.1.5 allows a remote attacker to obtain sensitive information and execute arbitrary code via the session management component.
AI Analysis
Technical Summary
CVE-2025-27953 is a medium-severity vulnerability affecting the Clinical Collaboration Platform version 12.2.1.5. The vulnerability resides in the session management component of the platform, allowing a remote attacker to both obtain sensitive information and execute arbitrary code on the affected system. The underlying weakness is associated with CWE-77, which relates to command injection vulnerabilities. This suggests that the session management component improperly handles user input or session data, enabling an attacker to inject malicious commands that the system executes. The CVSS 3.1 base score is 6.5, reflecting a network attack vector (AV:N), low attack complexity (AC:L), no privileges required (PR:N), and no user interaction needed (UI:N). The impact affects confidentiality and integrity, allowing data disclosure and unauthorized code execution, but does not affect availability. No known exploits are currently reported in the wild, and no patches or vendor information are provided yet. Given the critical role of clinical collaboration platforms in healthcare environments, this vulnerability poses a significant risk to patient data confidentiality and system integrity if exploited.
Potential Impact
For European organizations, especially healthcare providers and institutions relying on the Clinical Collaboration Platform 12.2.1.5, this vulnerability could lead to unauthorized disclosure of sensitive patient information, violating GDPR and other data protection regulations. The ability to execute arbitrary code remotely without authentication could allow attackers to implant malware, disrupt clinical workflows, or pivot to other internal systems, potentially causing operational disruptions and reputational damage. The healthcare sector in Europe is a high-value target for cybercriminals and nation-state actors due to the sensitive nature of data and critical services provided. Exploitation could also lead to regulatory fines and loss of patient trust. The lack of patches increases the urgency for immediate mitigation to prevent exploitation.
Mitigation Recommendations
1. Implement network-level controls to restrict access to the Clinical Collaboration Platform, such as IP whitelisting and VPN-only access, to reduce exposure to remote attackers. 2. Employ Web Application Firewalls (WAFs) with custom rules to detect and block command injection attempts targeting session management endpoints. 3. Conduct thorough input validation and sanitization on all session-related inputs, if possible through configuration or vendor updates. 4. Monitor logs for unusual session management activity or unexpected command execution patterns. 5. Isolate the platform within segmented network zones to limit lateral movement if compromise occurs. 6. Engage with the vendor or community for patches or updates and apply them promptly once available. 7. Perform regular security assessments and penetration testing focused on session management components. 8. Educate IT and security teams on this specific vulnerability to enhance detection and response capabilities.
Affected Countries
Germany, France, United Kingdom, Italy, Spain, Netherlands, Sweden, Belgium
CVE-2025-27953: n/a
Description
An issue in Clinical Collaboration Platform 12.2.1.5 allows a remote attacker to obtain sensitive information and execute arbitrary code via the session management component.
AI-Powered Analysis
Technical Analysis
CVE-2025-27953 is a medium-severity vulnerability affecting the Clinical Collaboration Platform version 12.2.1.5. The vulnerability resides in the session management component of the platform, allowing a remote attacker to both obtain sensitive information and execute arbitrary code on the affected system. The underlying weakness is associated with CWE-77, which relates to command injection vulnerabilities. This suggests that the session management component improperly handles user input or session data, enabling an attacker to inject malicious commands that the system executes. The CVSS 3.1 base score is 6.5, reflecting a network attack vector (AV:N), low attack complexity (AC:L), no privileges required (PR:N), and no user interaction needed (UI:N). The impact affects confidentiality and integrity, allowing data disclosure and unauthorized code execution, but does not affect availability. No known exploits are currently reported in the wild, and no patches or vendor information are provided yet. Given the critical role of clinical collaboration platforms in healthcare environments, this vulnerability poses a significant risk to patient data confidentiality and system integrity if exploited.
Potential Impact
For European organizations, especially healthcare providers and institutions relying on the Clinical Collaboration Platform 12.2.1.5, this vulnerability could lead to unauthorized disclosure of sensitive patient information, violating GDPR and other data protection regulations. The ability to execute arbitrary code remotely without authentication could allow attackers to implant malware, disrupt clinical workflows, or pivot to other internal systems, potentially causing operational disruptions and reputational damage. The healthcare sector in Europe is a high-value target for cybercriminals and nation-state actors due to the sensitive nature of data and critical services provided. Exploitation could also lead to regulatory fines and loss of patient trust. The lack of patches increases the urgency for immediate mitigation to prevent exploitation.
Mitigation Recommendations
1. Implement network-level controls to restrict access to the Clinical Collaboration Platform, such as IP whitelisting and VPN-only access, to reduce exposure to remote attackers. 2. Employ Web Application Firewalls (WAFs) with custom rules to detect and block command injection attempts targeting session management endpoints. 3. Conduct thorough input validation and sanitization on all session-related inputs, if possible through configuration or vendor updates. 4. Monitor logs for unusual session management activity or unexpected command execution patterns. 5. Isolate the platform within segmented network zones to limit lateral movement if compromise occurs. 6. Engage with the vendor or community for patches or updates and apply them promptly once available. 7. Perform regular security assessments and penetration testing focused on session management components. 8. Educate IT and security teams on this specific vulnerability to enhance detection and response capabilities.
Affected Countries
For access to advanced analysis and higher rate limits, contact root@offseq.com
Technical Details
- Data Version
- 5.1
- Assigner Short Name
- mitre
- Date Reserved
- 2025-03-11T00:00:00.000Z
- Cvss Version
- null
- State
- PUBLISHED
Threat ID: 683de64b182aa0cae24f7c45
Added to database: 6/2/2025, 5:58:35 PM
Last enriched: 7/11/2025, 7:17:22 AM
Last updated: 7/30/2025, 4:11:37 PM
Views: 11
Related Threats
CVE-2025-8987: SQL Injection in SourceCodester COVID 19 Testing Management System
MediumCVE-2025-8986: SQL Injection in SourceCodester COVID 19 Testing Management System
MediumCVE-2025-31987: CWE-405 Asymmetric Resource Consumption in HCL Software Connections Docs
MediumCVE-2025-8985: SQL Injection in SourceCodester COVID 19 Testing Management System
MediumCVE-2025-8984: SQL Injection in itsourcecode Online Tour and Travel Management System
MediumActions
Updates to AI analysis are available only with a Pro account. Contact root@offseq.com for access.
External Links
Need enhanced features?
Contact root@offseq.com for Pro access with improved analysis and higher rate limits.